Poor glycemic control in type 2 diabetes in the South of the Sahara: The issue of limited access to an HbA1c test

Diabetes Research and Clinical Practice

Volumn 108, Issue 1, 2015, Pages 187-192

  Camara, Alioune ^a,b   Baldé, Naby M ^a   Sobngwi Tambekou, Joelle ^c   Kengne, André P ^d   Diallo, Mansour M ^a   Tchatchoua, Alain P K ^e   Kaké, Amadou ^a   Sylvie, Ngamani ^e   Balkau, Beverley ^f   Bonnet, Fabrice ^b   Sobngwi, Eugène ^e,g  

^a University Hospital   (Guinea)

^b RENNES UNIVERSITY HOSPITAL   (France)

^c Burundi   (Cameroon)

^d SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^e YAOUNDÉ CENTRAL HOSPITAL   (Cameroon)

^f INSERM   (France)

^g NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Glycemic control; Sub Saharan Africa; Type 2 diabetes

Indexed keywords

HEMOGLOBIN A1C; INSULIN; ORAL ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN;

ADULT; AGE; AGED; ARTICLE; BLOOD PRESSURE REGULATION; BODY MASS; CAMEROON; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DIASTOLIC BLOOD PRESSURE; DISEASE DURATION; FEMALE; GLYCEMIC CONTROL; GUINEA; HEALTH CARE ACCESS; HEMOGLOBIN BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT MONITORING; PREVALENCE; SYSTOLIC BLOOD PRESSURE; ANALYSIS; BLOOD; BLOOD GLUCOSE MONITORING; CLINICAL TRIAL; DIABETES MELLITUS, TYPE 2; GLUCOSE BLOOD LEVEL; MIDDLE AGED; MULTICENTER STUDY; ODDS RATIO; PROCEDURES; RETROSPECTIVE STUDY;

BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; BODY MASS INDEX; CAMEROON; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GUINEA; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; PREVALENCE; RETROSPECTIVE STUDIES;

EID: 84926146938     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2014.08.025     Document Type: Article

References (28)

1. Guariguata L., Whiting D.R., Hambleton I., Beagley J., Linnenkamp U., Shaw J.E. Global estimates of diabetes prevalence in adults for 2013 and projections for 2035 for the IDF Diabetes Atlas. Diabetes Res Clin Pract 2014, 103(2):137-149.
2. Hall V., Thomsen R.W., Henriksen O., Lohse N. Diabetes in Sub Saharan Africa 1999-2011: epidemiology and public health implications. A systematic review. BMC Public Health 2011, 11(1):564.
3. Mbanya J.C.N., Motala A.A., Sobngwi E., Assah F.K., Enoru S.T. Diabetes in sub-Saharan Africa. Lancet 2010, 375(9733):2254-2266.
4. UK Prospective Diabetes Study (UKPDS) Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998, 352(9131):837-853.
5. Karter A.J., Moffet H.H., Liu J., Parker M.M., Ahmed A.T., Ferrara A., et al. Achieving good glycemic control: initiation of new antihyperglycemic therapies in patients with type 2 diabetes from the Kaiser Permanente Northern California Diabetes Registry. Am J Manag Care 2005, 11(4):262.
6. Sobngwi E., Ndour-Mbaye M., Boateng K.A., Ramaiya K.L., Njenga E.W., Diop S.N., et al. Type 2 diabetes control and complications in specialised diabetes care centres of six sub-Saharan African countries: the Diabcare Africa study. Diabetes Res Clin Pract 2012, 95(1):30-36.
7. Sobngwi E., Balde N. De la théorie à la pratique: améliorer l'accès à la mesure de l'HbA1C en Afrique Sub-saharienne. Diabetes Voice 2011, 56:36-39.
8. ® analyzer for HbA1c determination. Diabetes Metab 2010, 36(2):158-164.
9. Marzullo C., Minery M., Guemazi F., Stojiljkovic D., Benoît M. Dosage délocalisé de l'hémoglobine A1c sur l'analyseur In2it™ dans le cadre d'une consultation de diabétologie pédiatrique. Immuno-Anal Biol Spéc 2010, 25(1):34-37.
10. American Diabetes Association Standards of medical care in diabetes-2014- Diabetes Care 2014, 37(Supplement_1):S14-S80.
11. Chan J.C.N., Gagliardino J.J., Baik S.H., Chantelot J.-M., Ferreira S.R.G., Hancu N., et al. Multifaceted determinants for achieving glycemic control the International Diabetes Management Practice Study (IDMPS). Diabetes Care 2009, 32(2):227-233.
12. Blaum C.S., Velez L., Hiss R.G., Halter J.B. Characteristics related to poor glycemic control in NIDDM patients in community practice. Diabetes Care 1997, 20(1):7-11.
13. Khattab M., Khader Y.S., Al-Khawaldeh A., Ajlouni K. Factors associated with poor glycemic control among patients with type 2 diabetes. J Diabetes Complications 2010, 24(2):84-89.
14. Otiniano M.E., Al Snih S., Goodwin J.S., Ray L., AlGhatrif M., Markides K.S. Factors associated with poor glycemic control in older Mexican American diabetics aged 75 years and older. J Diabetes Complications 2012, 26(3):181-186.
15. Benoit S., Fleming R., Philis-Tsimikas A., Ji M. Predictors of glycemic control among patients with type 2 diabetes: a longitudinal study. BMC Public Health 2005, 5(1):36.
16. Verma M., Paneri S., Badi P., Raman P.G. Effect of increasing duration of diabetes mellitus type 2 on glycated hemoglobin and insulin sensitivity. Indian J Clin Biochem 2006, 21(1):142-146.
17. Arner P., Pollare T., Lithell H. Different aetiologies of type 2 (non-insulin-dependent) diabetes mellitus in obese and non-obese subjects. Diabetologia 1991, 34(7):483-487.
18. Chiu C.J., Wray L.A. Factors predicting glycemic control in middle-aged and older adults with type 2 diabetes. Prev Chronic Dis 2010, 7.(1):A08. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2811503/ Accessed [cited 2015 Feb 4].
19. El-Kebbi I.M., Cook C.B., Ziemer D.C., Miller C.D., Gallina D.L., Phillips L.S. ASsociation of younger age with poor glycemic control and obesity in urban african americans with type 2 diabetes. Arch Intern Med 2003, 163(1):69-75.
20. Rothenbacher D., Rüter G., Saam S., Brenner H. Younger patients with type 2 diabetes need better glycaemic control: results of a community-based study describing factors associated with a high HbA1c value. Br J Gen Pract 2003, 53(490):389.
21. Ko S-H., Park S-A., Cho J-H., Ko S-H., Shin K-M., Lee S-H., et al. Influence of the duration of diabetes on the outcome of a diabetes self-management education program. Diabetes Metab J 2012, 36(3):222.
22. Al-Nuaim A.R., Mirdad S., Al-Rubeaan K., Al-Mazrou Y., Al-Attas O., Al-Daghari N. Pattern and factors associated with glycemic control of Saudi diabetic patients. Ann Saudi Med 1998, 18(2):109-112.
23. Valle T., Koivisto V.A., Reunanen A., Kangas T., Rissanen A. Glycemic control in patients with diabetes in Finland. Diabetes Care 1999, 22(4):575-579.
24. Fox K.M., Gerber P.R.A., Bolinder B., Chen J., Kumar S. Prevalence of inadequate glycemic control among patients with type 2 diabetes in the United Kingdom general practice research database: a series of retrospective analyses of data from 1998 through 2002. Clin Ther 2006, 28(3):388.
25. Rahlenbeck S.I. Monitoring of glycemic balance in diabetics living in Africa: a review of glycated hemoglobin measurement methods. Santé Montrouge Fr 2002, 12(3):337-341.
26. Inzucchi S.E., Bergenstal R.M., Buse J.B., Diamant M., Ferrannini E., Nauck M., et al. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012, 35(6):1364-1379.
27. Cagliero E., Levina E.V., Nathan D.M. Immediate feedback of HbA1c levels improves glycemic control in type 1 and insulin-treated type 2 diabetic patients. Diabetes Care 1999, 22(11):1785-1789.
28. Dorchy H., Roggemans M.P., Willems D. Glycated hemoglobin and related factors in diabetic children and adolescents under 18 years of age: a Belgian experience. Diabetes Care 1997, 20(1):2-6.